Iain Stuart
CIK 1727756 · CHIEF SCIENTIFIC OFFICER · last filed 2026-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$54.8K
Companies
3
Total Filings
45
Lifetime Open-Market Net
-$27.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | CHIEF SCIENTIFIC OFFICER | 1,919 | $28.56 | $54.8K | $0 | 30 | 2026-07-24 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Chief Scientific Officer | 291,018 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Chief Scientific Officer | 103,636 | — | — | -$27.1K | 9 | 2020-02-24 |
Recent Filings · Page 3 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-04 | VYNE | Tax (F) | −3,469 | -$2.3K | EDGAR |
| 2022-03-18 | VYNE | Grant (A) | +75,000 | $0 | EDGAR |
| 2022-01-04 | VYNE | Tax (F) | −1,250 | -$1.3K | EDGAR |
| 2021-10-01 | VYNE | Tax (F) | −1,480 | -$2.1K | EDGAR |
| 2021-09-03 | VYNE | Grant (A) | +60,859 | $0 | EDGAR |
| 2021-07-02 | VYNE | Tax (F) | −3,083 | -$10.8K | EDGAR |
| 2021-04-02 | VYNE | Tax (F) | −1,945 | -$13.3K | EDGAR |
| 2021-02-24 | VYNE | Grant (A) | +29,213 | $0 | EDGAR |
| 2021-01-05 | VYNE | Tax (F) | −2,378 | -$3.8K | EDGAR |
| 2020-10-02 | VYNE | Tax (F) | −2,378 | -$3.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.